Peter O’Callaghan holds BSc and PhD degrees in Genetics from Newcastle University. Since graduation he has gained over 10 years’experience in biotechnology research and development in academia and industry, during which time he co-authored patents as well as research articles and reviews in international peer-reviewed scientific journals and books.
Since 2011 he has been woking in the New Expression Technologies group at Lonza Biologics in Cambridge. He works as an Principle Scientist where he is responsible for the development and commercial implementation of new gene expression technologies, cell lines, and tools for recombinant therapeutic protein production using CHO cell lines. He also leads R&D strategies for developing next-generation technologies and processes, in addition to supporting commercial launch and associated promotional work
Looks like your search is too specific.
Please try again with something more general.